Fresenius Medical Care stock steadies after JPMorgan cuts rating

Published on 09/12/2026 at 14:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius Medical Care stock traded at EUR 38.44 on September 8, 2026 after a 0.1 percent dip on Xetra. JPMorgan cut the rating to Underweight on September 9, 2026.

Moderner Dialyseraum mit Hämodialysegeräten und Patientenliegen bei Tageslicht — Ein fotorealistisches Bild eines modernen Dialyseraums mit mehreren Hämodialysegeräten und Patientenliegen in Reihe, ruhigem Tageslicht durch große Fenster – typisch für die Behandlungszentren von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

Fresenius Medical Care stock (ISIN DE0005785802) traded at EUR 38.44 on Xetra on September 8, 2026, after slipping 0.1 percent, while the Frankfurt quote in the same report showed EUR 39.03 and a 1.72 percent move.

JPMorgan turns cautious

According to finanzen.net on September 12, 2026, JPMorgan Chase & Co. rated Fresenius Medical Care Underweight on September 9, 2026. The same table also listed Jefferies & Company Inc. as Underperform on August 7, 2026.

The average analyst target cited by finanzen.net stood at EUR 42.02, which leaves the Xetra quote of EUR 38.44 about EUR 3.58 below that mark. That gap is 9.3 percent.

Guidance stays in place

Simply Wall St said on September 11, 2026 that Fresenius Medical Care confirmed its 2026 earnings guidance and continued to expect broadly flat revenue development. The company has also pointed investors to its IR hub at Fresenius Medical Care investor relations.

For the recent reported backdrop, finanzen.net showed a Xetra last price of EUR 39.50 on September 8, 2026, with turnover of 88,031 shares and a day range of EUR 39.33 to EUR 39.69. In the same snapshot, market capitalization was listed at CHF 9.83 billion and the stock was quoted at 39.50 EUR.

Stock near EUR 40

Fresenius Medical Care stock closed the Xetra snapshot on September 8, 2026 at EUR 38.44, while the broader quote table in the same market set showed EUR 39.50 earlier in the session. The share price remains close to the EUR 40 mark.